Scienture Holdings, Inc. Common Stock (SCNX) is a publicly traded Healthcare sector company. As of May 21, 2026, SCNX trades at $0.39 with a market cap of $15.99M and a P/E ratio of -0.14. SCNX moved -2.15% today. Year to date, SCNX is -25.14%; over the trailing twelve months it is -57.40%. Its 52-week range spans $0.24 to $9.55. Analyst consensus is buy with an average price target of $1.50. Rallies surfaces SCNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own SCNX include Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Scienture Holdings, Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $0.39 |
| Market Cap | $15.99M |
| P/E Ratio | -0.14 |
| EPS | $-2.70 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.55 |
| 52-Week Low | $0.24 |
| Volume | 6.76K |
| Avg Volume | 0 |
| Revenue (TTM) | $431.61K |
| Net Income | $-41.51M |
| Gross Margin | 76.80% |
1 analysts cover SCNX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.50.